These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 17617019)

  • 1. Pharmacogenomics and adverse drug reactions in diagnostic and clinical practice.
    Manolopoulos VG
    Clin Chem Lab Med; 2007; 45(7):801-14. PubMed ID: 17617019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosing recommendations for pharmacogenetic interactions related to drug metabolism.
    Filipski KK; Pacanowski MA; Ramamoorthy A; Feero WG; Freedman AN
    Pharmacogenet Genomics; 2016 Jul; 26(7):334-9. PubMed ID: 27058883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenomics of adverse drug reactions: practical applications and perspectives.
    Becquemont L
    Pharmacogenomics; 2009 Jun; 10(6):961-9. PubMed ID: 19530963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in pharmacogenetics and pharmacogenomics.
    Vesell ES
    J Clin Pharmacol; 2000 Sep; 40(9):930-8. PubMed ID: 10975065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bench to bedside: Pharmacogenomics, adverse drug interactions, and the cytochrome P450 system.
    Sikka R; Magauran B; Ulrich A; Shannon M
    Acad Emerg Med; 2005 Dec; 12(12):1227-35. PubMed ID: 16282513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenomics of drug-metabolizing enzymes: a recent update on clinical implications and endogenous effects.
    Sim SC; Kacevska M; Ingelman-Sundberg M
    Pharmacogenomics J; 2013 Feb; 13(1):1-11. PubMed ID: 23089672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenomics: bridging the gap between science and practice.
    Lee KC; Ma JD; Kuo GM
    J Am Pharm Assoc (2003); 2010; 50(1):e1-14; quiz e15-7. PubMed ID: 20368146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research.
    Arranz MJ; de Leon J
    Mol Psychiatry; 2007 Aug; 12(8):707-47. PubMed ID: 17549063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translating pharmacogenomics: challenges on the road to the clinic.
    Swen JJ; Huizinga TW; Gelderblom H; de Vries EG; Assendelft WJ; Kirchheiner J; Guchelaar HJ
    PLoS Med; 2007 Aug; 4(8):e209. PubMed ID: 17696640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetics and the concept of individualized medicine.
    Shastry BS
    Pharmacogenomics J; 2006; 6(1):16-21. PubMed ID: 16302022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenomics in cardiovascular clinical trials.
    Shah R; Darne B; Atar D; Abadie E; Adams KF; Zannad F;
    Fundam Clin Pharmacol; 2004 Dec; 18(6):705-8. PubMed ID: 15548243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress in pharmacogenomics and its promise for medicine.
    Blake CA; Sobel BE
    Exp Biol Med (Maywood); 2008 Dec; 233(12):1482-3. PubMed ID: 18849537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory approval for new pharmacogenomic tests: a comparative overview.
    Joly Y; Koutrikas G; Tassé AM; Issa A; Carleton B; Hayden M; Rieder MJ; Ramos-Paque E; Avard D
    Food Drug Law J; 2011; 66(1):1-24, i. PubMed ID: 24505844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenomics: historical perspective and current status.
    Charlab R; Zhang L
    Methods Mol Biol; 2013; 1015():3-22. PubMed ID: 23824846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current pharmacogenomic approaches to clinical drug development.
    Murphy MP
    Pharmacogenomics; 2000 May; 1(2):115-23. PubMed ID: 11256585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of cost-effectiveness analysis in the era of pharmacogenomics.
    Flowers CR; Veenstra D
    Pharmacoeconomics; 2004; 22(8):481-93. PubMed ID: 15217305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trials in pharmacogenetics and pharmacogenomics: methods and applications.
    Rioux PP
    Am J Health Syst Pharm; 2000 May; 57(9):887-98; quiz 899-901. PubMed ID: 10840530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotyping as a tool to predict adverse drug reactions.
    Güzey C; Spigset O
    Curr Top Med Chem; 2004; 4(13):1411-21. PubMed ID: 15379654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenomics in anticoagulant drug development.
    Iqbal O
    Pharmacogenomics; 2002 Nov; 3(6):823-8. PubMed ID: 12437483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implications of pharmacogenomics for anesthesia providers.
    Ama T; Bounmythavong S; Blaze J; Weismann M; Marienau MS; Nicholson WT
    AANA J; 2010 Oct; 78(5):393-9. PubMed ID: 21067087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.